Last edition
News about "Life Molecular Imaging "
LMI and PharmaLogic to Supply Neuraceq in Denver
Neuraceq is an FDA-approved imaging agent for the detection of beta-amyloid plaques in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive decline.
Life Molecular Imaging | 21/08/2024 | By Aishwarya
Life Molecular Imaging Expands Partnership with Jubilant Radiopharma to Distribute Neurace
Life Molecular Imaging (LMI) has expanded their strategic partnership and licensing agreement with Jubilant Radiopharma to provide and distribute Neuraceq from Jubilant's single photon emission computed tomography (SPECT) and Positron Emision Tomography (PET) radiopharmaceutical manufacturing site located in Mobile, AL.
Life Molecular Imaging | 10/07/2024 | By Aishwarya | 136
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy